(AIP) Arteris - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US04302A1043

AIP: Interconnect, IP, Silicon, Cache, Integration, Software

Arteris Inc. (NASDAQ: AIP) provides system intellectual property (IP) solutions for semiconductors, specializing in on-chip communications and IP block deployment for System-on-Chip (SoC) designs and chiplet-based systems. The companys portfolio includes Network-on-Chip (NoC) IP products such as FlexGen, FlexNoC, and FlexWay, which offer non-coherent NoC solutions, as well as Ncore, a cache-coherent NoC IP, and CodaCache, a last-level cache solution. Additionally, Arteris provides SoC integration automation software, including Magillem for connectivity and register management and CSRCompiler for IP and SoC software development. The company also offers professional services like training, design assistance, and consulting, along with licensing services for software and intellectual property, IP support, and on-site support. Arteris serves industries such as automotive, communications, enterprise computing, consumer electronics, and industrial sectors. Founded in 2003, the company is headquartered in Campbell, California. Web URL: https://www.arteris.com

Based on technical and fundamental data, here is a 3-month forecast: - Technical Outlook: AIP is currently trading below its 20-day SMA (9.73) and 50-day SMA (10.41), indicating bearish momentum. However, the 200-day SMA (8.47) suggests support near current levels. Average true range (ATR) of 0.70 indicates moderate volatility, with potential price fluctuations between 8.18 and 9.58 over the next quarter. - Fundamental Analysis: With a market cap of $380M and P/S ratio of 6.58, AIP is valued at a premium relative to its peers. The high P/B ratio of 56.04 reflects investor confidence in future growth, though profitability metrics remain absent. The companys focus on automotive and enterprise computing sectors could drive near-term revenue stability. - Key Risks: The stocks reliance on licensing revenue and high valuation multiples pose risks. Any weakness in semiconductor demand or delays in customer adoption could impact short-term performance. Investors should monitor SMA crossovers and revenue guidance for directional cues.

Additional Sources for AIP Stock

AIP Stock Overview

Market Cap in USD 323m
Sector Technology
Industry Semiconductors
GiC Sub-Industry Semiconductors
IPO / Inception 2021-10-27

AIP Stock Ratings

Growth 5y -24.4%
Fundamental -1.20%
Dividend 0.0%
Rel. Strength Industry 14.4
Analysts 4.6/5
Fair Price Momentum 6.41 USD
Fair Price DCF -

AIP Dividends

No Dividends Paid

AIP Growth Ratios

Growth Correlation 3m -62.3%
Growth Correlation 12m 57.6%
Growth Correlation 5y -16%
CAGR 5y -22.69%
CAGR/Max DD 5y -0.26
Sharpe Ratio 12m -0.06
Alpha -3.04
Beta 2.69
Volatility 64.04%
Current Volume 80.7k
Average Volume 20d 232.9k
What is the price of AIP stocks?
As of March 15, 2025, the stock is trading at USD 7.63 with a total of 80,681 shares traded.
Over the past week, the price has changed by -3.30%, over one month by -21.82%, over three months by -21.98% and over the past year by +18.66%.
Is Arteris a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Arteris is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -1.20 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AIP as of March 2025 is 6.41. This means that AIP is currently overvalued and has a potential downside of -15.99%.
Is AIP a buy, sell or hold?
Arteris has received a consensus analysts rating of 4.60. Therefor, it is recommend to buy AIP.
  • Strong Buy: 4
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for AIP stock price target?
According to ValueRays Forecast Model, AIP Arteris will be worth about 7.6 in March 2026. The stock is currently trading at 7.63. This means that the stock has a potential downside of -0.52%.
Issuer Forecast Upside
Wallstreet Target Price 13.2 73%
Analysts Target Price 11.2 46.8%
ValueRay Target Price 7.6 -0.5%